COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,789 Articles (22,946 medRxiv, 8,843 bioRxiv)

Most recent first Previous |  Page 1894: Articles 18931-18940  | Next

COVID-19 risk perceptions of social interaction and essential activities and inequity in the United States: Results from a nationally representative survey
Erchick, D. J., Zapf, A. J., Baral, P., Edwards, J., Mehta, S. H., Solomon, S. S., Gibson, D. G., Agarwal, S., Labrique, A. B.
10.1101/2021.01.30.21250705 — Posted: 2021-02-02
A Logistic Formula in Biology and Its Application to Deaths by the Third Wave of COVID-19 in Japan
Saito, T.
10.1101/2021.01.30.21250827 — Posted: 2021-02-02
Sustainable targeted interventions to mitigate the COVID-19 pandemic: A big data-driven modeling study in Hong Kong
ZHOU, H., Zhang, Q., Cao, Z., Huang, H., Zeng, D.
10.1101/2021.01.29.21250786 — Posted: 2021-02-02
COVID-19 vaccine acceptability and inequity in the United States: Results from a nationally representative survey
Gibson, D. G., Agarwal, S., Meghani, A., Limaye, R., Labrique, A. B.
10.1101/2021.01.29.21250784 — Posted: 2021-02-02
Radius of Gyration as predictor of COVID-19 deaths trend with three-weeks offset
Hernando de Castro, A., Mateo, D., Bayer, J., Barrios, I.
10.1101/2021.01.30.21250708 — Posted: 2021-02-02
Neutralization of SARS-CoV-2 VOC 501Y.V2 by human antisera elicited by both inactivated BBIBP-CorV and recombinant dimeric RBD ZF2001 vaccines
Huang, B., Dai, L., Wang, H., Hu, Z., Tan, W., Gao, G. F., Yang, X.
10.1101/2021.02.01.429069 — Posted: 2021-02-02 Discussion: Onsite
Production of SARS-CoV-2 virus-like particles in insect cells
mi, Y., Xie, T., Zhu, B., tan, J., Li, X., Luo, Y., Li, F., Niu, H., Han, J., Lv, W., Wang, J.
10.1101/2021.01.30.428979 — Posted: 2021-02-01
Host PDZ-containing proteins targeted by SARS-Cov-2
Caillet-Saguy, C., Durbesson, F., REZELJ, V. V., Gogl, G., Tran, Q. D., Twizere, J.-C., Vignuzzi, M., Vincentelli, R., Wolff, N.
10.1101/2021.02.01.429176 — Posted: 2021-02-01
In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinically relevant concentrations and timeframes using tissue culture and PCR based assays
Tucker, S. P., Goodall, S., Molloy, P., Julander, J., Mendenhall, M., Friedland, P.
10.1101/2021.01.31.426979 — Posted: 2021-02-01
Enhanced immunogenicity of a synthetic DNA vaccine expressing consensus SARS-CoV-2 Spike protein using needle-free immunization
Alamri, S. S., Alluhaybi, K. A., Alhabbab, R. Y., Algaissi, A., Almahboub, S., Alfaleh, M. A., Abujamel, T. S., Abdulaal, W., ElAssouli, M.-Z., Alharbi, R., Hassanain, M., Hashem, A. M.
10.1101/2021.02.01.429219 — Posted: 2021-02-01 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).